NCT05139017 · Interventional trial
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
Overall registry status Recruiting
Phase 2 · Phase 3
Conditions DLBCL, Diffuse Large B-Cell Lymphoma
Delaware Valley sites
- Alliance Cancer Specialists (ACS) ( Site 8001) · Horsham, PA · Montgomery County · Recruiting
First posted
Registry updated
Added to the directory